A mother's desperation for a miracle was met with one when pioneering ultrasound treatment saved her identical twin daughters from a rare and potentially fatal pregnancy condition. The groundbreaking medical procedure, which harnesses the power of high-powered sound waves to treat twin-to-twin transfusion syndrome (TTTS), has shown promising results in clinical trials. This life-threatening condition, affecting around 10-15% of identical twin pregnancies that share a placenta, can lead to catastrophic consequences for both babies if left untreated.
For Brioney Garrett and her identical twins, Nancy and Margo, the cutting-edge treatment proved to be a lifeline. Using focused ultrasound waves, doctors at Queen Charlotte's and Chelsea Hospital in London sealed the specific blood vessels causing the imbalance, bypassing the need for more invasive surgical interventions. The results were nothing short of remarkable – the twins were born healthy four years ago and are now thriving as they prepare to start school.
TTTS affects approximately 300-400 identical twin pregnancies annually in the UK, translating to around 10-15% of all cases. If left untreated, it can lead to one baby receiving too much blood and fluid, while the other receives too little, potentially harming both. Traditional treatments typically involve inserting a needle into the womb or using a laser to seal the problematic blood vessels. In contrast, this new ultrasound method offers a non-invasive alternative that takes around 20 minutes and is described as 'quick and painless' by Ms Garrett.
The trial involved 10 women from the UK and across Europe, with their 20 twin babies receiving treatment. The results showed that 12 of the babies survived after the procedure, although half of the mothers required further intervention. Researchers from Imperial College Healthcare NHS Trust found that the ultrasound successfully blocked blood flow in 90% of the targeted blood vessels, with no reported unwanted side effects. Professor Christoph Lees, head of fetal medicine at the Trust, described the research as 'very promising', highlighting its potential to offer hope to families impacted by this life-threatening condition.
While standard ultrasound is widely used and considered safe for imaging, this new therapeutic ultrasound generates heat to seal blood vessels as small as 2mm in diameter, several centimetres below the skin. The charity Twins Trust, which supported the study, believes that this non-invasive approach could be a game-changer for families affected by TTTS. However, researchers stress that larger studies involving more pregnant women are necessary to conclusively demonstrate its effectiveness before it can be offered widely across the NHS.